Evidence map›Paper›PMID 27484063›Full record

ArticleJournal of assisted reproduction and genetics2016

Perifollicular blood flow and its relationship with endometrial vascularity, follicular fluid EG-VEGF, IGF-1, and inhibin-a levels and IVF outcomes.

Fisun Vural, Birol Vural, Emek Doğer, Yiğit Çakıroğlu, Mustafa Çekmen

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04444245 (Re-establishment of Ovarian Hormonal Function, Delay of Menopause, or Reversal of Early Menopause With High Density), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04444245 phase1unknown statusnot on this mapstarted 2022, after this paper: background citation

Re-establishment of Ovarian Hormonal Function, Delay of Menopause, or Reversal of Early Menopause With High Density (HD PRP), tSVF + PRP, or Cell Enriched tSVF + PRP by Ultrasound Guided Ovarian Injection

TypeinterventionalSponsorBlack Tie Medical, Inc.Ran2022 to 2025Enrolled100ConditionsOvarian Failure, Perimenopausal Disorder, Hormone DisturbanceArmslipoaspiration harvest tSVF, Platelet Rich Plasma, Endovaginal Ultrasound, Cellular Isolation cSVF, Normal Saline (NS) .9% 10 mL Injection
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Follicular fluid estradiol is an improved predictor ofExperimental and therapeutic medicine · 2020
    Article
  6. The role of color Doppler in assisted reproduction: A narrative review.International journal of reproductive biomedicine · 2019
    Review
  7. Article
  8. Effects of VEGFStem cell reviews and reports · 2019
    Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fisun VuralDepartment of Obstetrics and Gynecology, Haydarpaşa Numune Training and Research Hospital, Tıbbiye cad. No:40 Üsküdar, Istanbul, Turkey. fisunvural@yahoo.com.tr.ORCID http://orcid.org/0000-0002-1103-7357
Birol VuralDepartment of Obstetrics and Gynecology, Assisted Reproductive Unit, Kocaeli University School of Medicine, Kocaeli, Turkey.
Emek DoğerDepartment of Obstetrics and Gynecology, Assisted Reproductive Unit, Kocaeli University School of Medicine, Kocaeli, Turkey.
Yiğit ÇakıroğluDepartment of Obstetrics and Gynecology, Assisted Reproductive Unit, Kocaeli University School of Medicine, Kocaeli, Turkey.
Mustafa ÇekmenDepartment of Biochemistry, Kocaeli University School of Medicine, Kocaeli, Turkey.
Kocaeli Üniversitesi · TRHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study is to investigate the association of perifollicular blood flow (PFBF) with follicular fluid EG-VEGF, inhibin-a, and insulin-like growth factor-1 (IGF-1) concentrations, endometrial vascularity, and IVF outcomes.

methodsForty women with tubal factor infertility were included in a prospective cohort study. Each woman underwent IVF/ICSI procedure. Individual follicles of ≥16 mm (n = 156) were evaluated by power Doppler analysis and categorized as well-vascularized follicles (WVFs) or poorly vascularized follicles (PVFs). WVFs referred to those with perifollicular vascularity of 51-100 %. Each follicular fluid (FF) was individually aspirated and FF/serum EG-VEGF, inhibin-a, and FF IGF-1 levels were evaluated. Zones III-IV endometrial vascularity was classified as a well-vascularized endometrium (WVE). The presence of a WVE and mature oocytes, in addition to the embryo quality and clinical pregnancy rate (CPR), were recorded for each follicle. The main outcome measures were FF serum EG-VEGF, inhibin-a, IGF-1 levels, and WVE and IVF outcome per PFBF.

resultsFor WVFs, the level of FF EG-VEGF (p = 0.008), oocyte quality (p = 0.001), embryo quality (p = 0.002), a WVE (p = 0.001), and CPR (p = 0.04) increased significantly. The pregnant group was characterized by increased numbers of WVFs (p = 0.044), a WVE (p = 0.022), and increased levels of FF IGF-1 (p = 0.001) and serum EG-VEGF (p = 0.03). FF IGF-1 >50 ng/mL (AUC 0.72) had 75 % sensitivity and 64 % specificity for predicting CPR.

conclusionsWVFs yield high-quality oocytes and embryos, a WVE, increased FF EG-VEGF levels, and increased CPRs.

Indexed as

AdultEndometriumFemaleFertilization in VitroFollicular FluidHumansInfertility, FemaleInhibinsInsulin-Like Growth Factor IOvarian FolliclePregnancyPregnancy RateSperm Injections, IntracytoplasmicVascular Endothelial Growth Factor, Endocrine-Gland-Derivedinhibin-alpha subunitInhibinsInsulin-Like Growth Factor IVascular Endothelial Growth Factor, Endocrine-Gland-DerivedEG-VEGFEndometrial blood flowEndometrial vascularityFollicular blood flowFollicular vascularityIGF-1Inhibin-a

Identifiers

PMID27484063
PMCPMC5065557
OpenAlexW2485197454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.